These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22998393)
1. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use. Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393 [TBL] [Abstract][Full Text] [Related]
2. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population. Abadie JM; Bankson DD Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511 [TBL] [Abstract][Full Text] [Related]
3. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695 [TBL] [Abstract][Full Text] [Related]
4. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof]. Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy. Wolff F; Thiry C; Willems D Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359 [TBL] [Abstract][Full Text] [Related]
6. Serum free light chain reference values: a critical approach. Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536 [TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
10. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser. Maisin D; Lepoutre T; Gruson D; Wallemacq P Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma]. Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965 [TBL] [Abstract][Full Text] [Related]
12. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications. Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638 [TBL] [Abstract][Full Text] [Related]
13. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study. Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots. Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies]. Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579 [TBL] [Abstract][Full Text] [Related]
16. [Progress in the management of multiple myeloma introduced by serum free light chain measurement]. Fuchida S; Shimazaki C Nihon Rinsho; 2011 Dec; 69(12):2267-73. PubMed ID: 22242331 [TBL] [Abstract][Full Text] [Related]
17. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
18. Analytical performance of the serum free light chain assay. Briand PY; Decaux O; Caillon H; Grosbois B; Le Treut A; Guenet L Clin Chem Lab Med; 2010; 48(1):73-9. PubMed ID: 19929752 [TBL] [Abstract][Full Text] [Related]
19. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645 [TBL] [Abstract][Full Text] [Related]
20. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]